Cargando…

Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival

Background: Esophageal adenocarcinoma (EAC) is highly aggressive and characterized by poor prognosis. AXL expression has been linked to Barrett's tumorigenesis and resistance to chemotherapy, which is associated with c-ABL intracellular localization. However, the molecular and functional relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jun, Abid, Fatma, Phillips, Sharon, Salaria, Safia N., Revetta, Frank L., Peng, Dunfa, Washington, Mary K., El-Rifai, Wael, Belkhiri, Abbes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477426/ https://www.ncbi.nlm.nih.gov/pubmed/32922529 http://dx.doi.org/10.7150/jca.47318

Ejemplares similares

APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts
por: Hong, Jun, et al.
Publicado: (2016)

AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma
por: Hong, Jun, et al.
Publicado: (2022)

Transcriptional upregulation of c‐MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
por: Hong, Jun, et al.
Publicado: (2018)

AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking()
por: Maacha, Selma, et al.
Publicado: (2018)

Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma
por: Saad, Rama, et al.
Publicado: (2013)

Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
por: Pidkovka, Nataliya, et al.
Publicado: (2023)

Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
por: Zhu, Shoumin, et al.
Publicado: (2019)

Location-Specific Epigenetic Regulation of the Metallothionein 3 Gene in Esophageal Adenocarcinomas
por: Peng, DunFa, et al.
Publicado: (2011)

Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis
por: Ballout, Farah, et al.
Publicado: (2022)

Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas
por: Peng, DunFa, et al.
Publicado: (2017)

DARPP-32: from neurotransmission to cancer
por: Belkhiri, Abbes, et al.
Publicado: (2016)

The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells
por: Dar, Altaf A, et al.
Publicado: (2008)

Aurora kinase A in gastrointestinal cancers: time to target
por: Katsha, Ahmed, et al.
Publicado: (2015)

Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
por: Lu, Heng, et al.
Publicado: (2022)

Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage
por: Zhou, Zhangjian, et al.
Publicado: (2019)

Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas
por: Wang, Qinggang, et al.
Publicado: (2014)

Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells
por: Vangamudi, Bhavatarini, et al.
Publicado: (2011)

Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
por: de Miguel-Pérez, Diego, et al.
Publicado: (2019)

Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia
por: Soutto, Mohammed, et al.
Publicado: (2019)

Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells
por: Sriramajayam, Kannappan, et al.
Publicado: (2021)

Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis
por: Peng, Dun-Fa, et al.
Publicado: (2014)

Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis
por: Zhu, Shoumin, et al.
Publicado: (2015)

Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia
por: Soutto, Mohammed, et al.
Publicado: (2017)

Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis
por: Soutto, Mohammed, et al.
Publicado: (2015)

t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer
por: Vangamudi, Bhavatarini, et al.
Publicado: (2010)

Cisplatin‐resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib
por: Wang, Lihong, et al.
Publicado: (2017)

Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma
por: Islam, Md Obaidul, et al.
Publicado: (2023)

APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas
por: Ballout, Farah, et al.
Publicado: (2022)

TFF1 activates p53 through down-regulation of miR-504 in gastric cancer
por: Soutto, Mohammed, et al.
Publicado: (2014)

Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis
por: Ryan, Daniel, et al.
Publicado: (2019)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
por: Khalafi, Shayan, et al.
Publicado: (2020)

The antioxidant response in Barrett's tumorigenesis: A double-edged sword
por: Peng, Dunfa, et al.
Publicado: (2021)

Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus
por: Chen, Lei, et al.
Publicado: (2023)

AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms
por: Beitzen-Heineke, Antonia, et al.
Publicado: (2021)

Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers
por: Pidkovka, Nataliya, et al.
Publicado: (2021)

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
por: Ghiso, Elena, et al.
Publicado: (2017)

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression
por: Sato, Katsuaki, et al.
Publicado: (2016)

The Significance of Tumor Budding and Immunohistochemical Axl Expression in Gallbladder Adenocarcinomas
por: Öz, Özden, et al.
Publicado: (2022)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q6ugep9681btscbjp0era4vqrg